Brind.

Leerink Partners assessed forecasts and Mizuho Securities analysts provided sales estimates for Acadia Pharmaceuticals on June 26, 2025.

1 report, 0 independent Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Leerink Partners assessed forecasts and Mizuho Securities analysts provided sales estimates for Acadia Pharmaceuticals on June 26, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Acadia Pharmaceuticals

    Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet